| Researcher |
Research Area |
|
Angela R Bradbury, MD |
- Director, Breast and Ovarian Cancer Risk Assessment
- Primary research focus areas are ethical dilemmas in the cancer prevention field and predictive genetic testing
- Research on how and when parents communicate their BRCA (breast cancer gene) mutation status to their children and the impact of early communication of genetic risk on children's health behaviors
|
| Carolyn Y. Fang, PhD |
- Program Leader
Director, Cancer Prevention and Control Program
Associate Professor
- Education, risk assessment, and evaluation of screening and prevention programs for individuals with a family history of cancer through The Margaret Dyson Family Risk Assessment Program (FRAP)
- Education directed towards women with benign breast disease through The Benign Breast Registry to Assess Valid Endpoints (BeBrave) Program
|
|
Veda N Giri, MD |
- Director, Prostate Cancer Risk Assessment
Assistant Professor in Cancer Prevention and Control, Medical Oncology, and Clinical Genetics
- Awarded the Special Interest Award by ACS to investigate the role of DNA mismatch repair defects in prostate cancer susceptibility
- Ongoing research into the genetic, molecular and proteomic pathways involved in cancer susceptibility, especially prostate cancer
|
|
Andrew K Godwin, PhD |
- Director, Clinical Molecular Genetics Laboratory
Director, Biosample Repository
Co-Leader, Women’s Cancer Program
Co-PI, Specialized Program of Research Excellence in Ovarian Cancer (SPORE)
Member, Department of Medical Oncology
- Primary focus directed at improving the understanding of the etiology of several types of cancer and assessing molecular-targeted therapies for the treatment of these diseases. Studies primarily involve three different types of cancer, gastrointestinal stromal tumors (GISTs), ovarian, and breast
|
|
Stuart R Lessin, MD |
- Director, Dermatology-Cutaneous Oncology Program
Professor
- Clinical research program established to investigate various aspects of cutaneous oncology. Skin cancers under investigation include melanoma, cutaneous T-cell lymphoma, and non-melanoma skin cancer (basal/squamous cell carcinoma)
|
|
Mary E Ropka, PhD, RN, FAAN |
- Assistant Professor
- Research focuses on understanding the diverse and multiple decisions that individuals and families face when dealing with hereditary cancer risk (HCR)
|
| Eric A. Ross, PhD |
- Senior Director, Academic Informatics
Assistant Professor
- Primary focus involves the use of information technology and quantitative methods in support of clinical, population and basic research
|
|
David S Weinberg, MD, MSc |
- Chair, Department of Medicine
- Research focus on cancer prevention, especially for patients who are at average risk for gastrointestinal cancers.
|